Haleon plc (HLN)
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
Sector: Perfumes, Cosmetics & Other Toilet Preparations
Industry: Drug Manufacturers - Specialty & Generic
Haleon plc
NYSE:HLNHealthcare · Drug Manufacturers - Specialty & Generic
PrePre-market+0.55%$9.19
Close$9.140.00%AH$9.14+0.55%Now$9.19
Close$9.14-0.11%AH$9.14+0.55%since
Mkt Cap$40.17B
Float747.74M
O/S4.4B
PM VOL7K sh
$ Vol≈$64K
RVOL0.22×
Inst Own13.9%
SI2.5%
Div Yield2.17%
Dilution
Financials Summary
Revenue$14.76B
Net Income$2.18B
Total Assets$43.6B
Free Cash Flow$2.64B
Debt & Equity
Debt 34%
Equity 66%
Total Debt$11.5B
Total Equity$21.95B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in HLN's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$43.6B
Liabilities$21.57B
Accounts Receivable$2.84B
Accounts Payable$4.98B
Inventory$1.37B
PP&E (Net)$2.67B
Goodwill$10.88B
Intangible Assets$23.4B
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $14.76B | $15.04B | $15.13B | $14.53B | $12.78B | $13.24B | $11.35B |
| YoY Growth | -1.8% | -0.6% | 4.1% | 13.8% | -3.5% | 16.7% | - |
| Cost of Revenue | $5.13B | $5.74B | $5.81B | $5.73B | $4.81B | $5.33B | $4.92B |
| Gross Profit | $9.35B | $9.3B | $9.32B | $8.8B | $7.96B | $7.91B | $6.43B |
| Gross Margin | 63.3% | 61.9% | 61.6% | 60.6% | 62.3% | 59.7% | 56.6% |
| Research and Development | $412.38M | $398.87M | $416.27M | $401.55M | $343.99M | $406.9M | $390.84M |
| Selling, General, and Administrative | $5.84B | $5.8B | $5.74B | $5.4B | $5.08B | $5.65B | $4.81B |
| Other | -$325.69M | $148.57M | $489.89M | $555.47M | $350.68M | -$283.76M | $22.75M |
| Total Operating Expenses | $5.93B | $6.35B | $6.65B | $6.36B | $5.77B | $5.77B | $5.23B |
| Operating Income (EBIT) | $3.23B | $2.95B | $2.67B | $2.44B | $2.19B | $2.14B | $1.2B |
| Operating Margin | 21.9% | 19.6% | 17.7% | 16.8% | 17.2% | 16.2% | 10.6% |
| Interest Expense | $445.11M | $527.36M | $554.13M | $464.94M | $21.42M | $34.33M | $37.57M |
| Interest Income | $102.11M | $73.62M | $18.74M | $92.33M | $17.4M | $24.03M | $34.15M |
| Other Income (Expense) | -$348.01M | -$396.19M | -$492.56M | -$277.07M | -$2.68M | -$9.37M | -$14.72M |
| Income Before Tax (EBT) | $2.88B | $2.56B | $2.18B | $2.17B | $2.19B | $2.13B | $1.19B |
| Income Tax Expense | $617.92M | $582.24M | $692M | $667.91M | $263.68M | $548.78M | $266.36M |
| Net Income | $2.18B | $1.93B | $1.4B | $1.42B | $1.86B | $1.53B | $876.71M |
| Net Income Margin | 14.8% | 12.8% | 9.3% | 9.8% | 14.6% | 11.6% | 7.7% |
| Supplementary Data | |||||||
| EPS | 0.36 | 0.32 | 0.24 | 0.24 | 0.30 | 0.24 | 0.14 |
| Diluted EPS | 0.36 | 0.32 | 0.24 | 0.24 | 0.30 | 0.24 | 0.14 |
| Weighted Average OS | 4.48B | 4.57B | 4.63B | 4.62B | 4.62B | 4.62B | 4.62B |
| EBITDA | $3.85B | $3.54B | $3.15B | $2.92B | $2.96B | $2.56B | $1.57B |
| EBITDA Margin | 26.1% | 23.5% | 20.8% | 20.1% | 23.2% | 19.3% | 13.8% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $1.77B | $2.94B | $1.4B | $915.53M | $554.13M | $447.06M | $455.09M |
| Short-Term Investments | $0 | $73.62M | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $1.77B | $3.01B | $1.4B | $915.53M | $554.13M | $447.06M | $455.09M |
| Accounts Receivable | $2.84B | $2.55B | $1.81B | $1.99B | $5.12B | $1.8B | $5.35B |
| Inventory | $1.37B | $1.59B | $1.88B | $1.8B | $1.27B | $1.27B | $1.62B |
| Other Current Assets | $104.22M | $298.48M | $1.21B | $580.9M | $6.69M | $3.1B | $317.22M |
| Total Current Assets | $6.08B | $7.65B | $6.45B | $5.43B | $7.03B | $6.7B | $7.78B |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $2.67B | $2.57B | $2.55B | $2.54B | $2.22B | $2.14B | $2.17B |
| Goodwill | $10.88B | $10.98B | $11.13B | $11.24B | $11.04B | $11.06B | $10.94B |
| Intangible Assets | $23.4B | $24.1B | $24.81B | $26.82B | $25.36B | $25.37B | $26.56B |
| Long-Term Investments | $101.55M | $109.76M | $87M | $58.89M | $30.79M | $0 | $4.02M |
| Deferred Tax Assets | $386.14M | $0 | $0 | $294.47M | $417.61M | $335.96M | $339.98M |
| Other Long-Term Assets | $140.29M | $512.64M | $555.47M | $210.14M | $10.71M | $68.26M | $13.38M |
| Total Long-Term Assets | $37.52B | $38.28B | $39.13B | $41.17B | $39.08B | $38.98B | $40.02B |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $43.6B | $45.93B | $45.58B | $46.6B | $46.11B | $45.68B | $47.8B |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $4.98B | $2.64B | $2.48B | $2.46B | $2.11B | $2.45B | $2.54B |
| Short-Term Debt | $1.12B | $1.92B | $813.8M | $526.03M | $1.17B | $465.79M | $643.81M |
| Current Income Tax Payable | $0 | $382.81M | $385.48M | $281.08M | $317.22M | $372.1M | $302.5M |
| Current Unearned Revenue | $45.43M | $0 | $0 | $30.79M | $14.72M | $14.72M | $9.37M |
| Other Current Liabilities | $23.94M | $927.57M | $2.1B | $2.15B | $1.91B | $1.28B | $1.22B |
| Total Current Liabilities | $6.59B | $7.78B | $6.21B | $5.85B | $5.67B | $5.37B | $5.71B |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $10.26B | $11.43B | $11.66B | $13.23B | $1.34M | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $376.12M | $0 | $500.59M |
| Long-Term Deferred Tax Liabilities | $4.31B | $4.49B | $4.67B | $4.82B | $4.49B | $0 | $4.7B |
| Other Long-Term Liabilities | $291.28M | $416.27M | $567.52M | $513.98M | $386.82M | $5.07B | $0 |
| Total Long-Term Liabilities | $14.98B | $16.44B | $16.98B | $18.72B | $5B | $5.21B | $5.39B |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $21.57B | $24.21B | $23.19B | $24.57B | $10.67B | $10.58B | $11.11B |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $120.25M | $121.8M | $123.14M | $123.14M | $1.34M | $1.34M | $1.34M |
| Retained Earnings | $21.59B | $36.5B | $36.77B | $35.78B | $50.84B | $50.55B | $6.83B |
| Comprehensive Income & Other | $448.94M | $1.02B | -$14.67B | $1.6B | -$15.57B | -$15.6B | $1.84B |
| Other Stockholders' Equity | $233.82M | -$14.99B | -$14.67B | -$14.04B | -$15.57B | -$15.6B | $29.73B |
| Total Equity | $21.95B | $21.64B | $22.23B | $21.86B | $35.28B | $34.95B | $36.57B |
| Minority Interest | $78.83M | $77.63M | $164.63M | $168.65M | $167.31M | $148.57M | $121.8M |
| Total Liabilities and Equity | $43.52B | $45.85B | $45.42B | $46.43B | $45.94B | $45.53B | $47.68B |
| Supplementary Data | |||||||
| Total Debt | $11.5B | $13.52B | $12.66B | $13.97B | $1.33B | $651.84M | $859.31M |
| Net Debt | $9.73B | $10.58B | $11.26B | $13.06B | $772.31M | $204.79M | $404.22M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | $2.18B | $1.93B | $1.75B | $1.5B | $1.86B | $1.58B | $919.54M |
| Depreciation & Amortization | $471.3M | $433.67M | $413.59M | $384.15M | $358.71M | $408.24M | $348.01M |
| Deferred Income Tax | $0 | $0 | $0 | $82.99M | $263.68M | $0 | $266.36M |
| Stock-Based Compensation | $0 | $136.53M | $117.79M | $104.4M | $78.97M | $84.32M | $77.63M |
| Changes in Working Capital: | |||||||
| Accounts Receivable | -$85.1M | -$417.61M | $50.86M | -$113.77M | $18.74M | $24.09M | -$76.29M |
| Inventory | $174.12M | $289.11M | -$175.34M | -$390.84M | -$22.75M | $174M | $310.53M |
| Accounts Payable | $163.64M | $0 | $149.91M | $517.99M | $54.88M | $187.39M | -$342.65M |
| Other Working Capital | $82.48M | $192.74M | -$168.65M | $228.88M | -$254.31M | -$365.41M | -$508.63M |
| Total Working Capital Change | $335.14M | $64.25M | -$143.22M | $242.27M | -$203.45M | $20.08M | -$617.04M |
| Other Non-Cash Items | $70.69M | $515.32M | $677.33M | $449.73M | -$543.43M | -$210.14M | $57.55M |
| Net Cash from Operating | $3.06B | $3.08B | $2.81B | $2.76B | $1.81B | $1.88B | $1.05B |
| Investing Activities | |||||||
| Capital Expenditures | -$540.68M | -$334.62M | -$313.21M | -$439.02M | -$398.87M | -$425.64M | -$325.25M |
| Acquisitions | -$210.77M | $0 | -$95.03M | $12.33B | $149.91M | $322.58M | $160.62M |
| Purchases of Investments | -$7.85M | $0 | $0 | -$12.33B | -$149.91M | $128.49M | $70.94M |
| Sales of Investments | $0 | $0 | $0 | $936.94M | $133.85M | $211.48M | $293.13M |
| Other Investing Activities | $0 | $1.04B | $228.88M | -$12.26B | $220.85M | $1.14B | $190.07M |
| Net Cash from Investing | -$759.31M | $706.72M | -$179.36M | -$11.76B | -$44.17M | $1.38B | $389.5M |
| Financing Activities | |||||||
| Debt Repaid | - | -$792.39M | $740.18M | -$12.7B | -$10.71M | -$37.48M | -$1.34M |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | -$856.19M | -$161.96M | -$50.86M | $0 | $0 | $0 | $0 |
| Dividends Paid | -$801.2M | -$762.94M | -$519.33M | -$3.59B | -$1.54B | -$3.17B | -$1.54B |
| Other Financing Activities | -$52.37M | -$1.92B | -$788.37M | $143.22M | -$128.49M | -$125.82M | $302.5M |
| Net Cash from Financing | -$3.42B | -$2.06B | -$2.1B | $9.25B | -$1.65B | -$3.26B | -$1.24B |
| Forex Effect | $89.15M | -$105.74M | -$20.08M | $20.08M | -$6.69M | -$8.03M | -$18.74M |
| Net Change in Cash | -$1.03B | $1.62B | $512.64M | $274.39M | $109.76M | -$8.03M | $184.71M |
| Supplementary Data | |||||||
| Operating Cash Flow | $3.06B | $3.08B | $2.81B | $2.76B | $1.81B | $1.88B | $1.05B |
| Capital Expenditure | -$421.55M | -$334.62M | -$449.73M | -$439.02M | -$398.87M | -$425.64M | -$325.25M |
| Free Cash Flow | $2.64B | $2.75B | $2.36B | $2.32B | $1.42B | $1.46B | $726.8M |
| Cash at Beginning | $2.8B | $1.33B | $817.82M | $543.43M | $432.33M | $440.36M | $255.65M |
| Cash at End | $1.77B | $2.95B | $1.33B | $817.82M | $542.09M | $432.33M | $440.36M |